Skip to main content
Fig. 6 | Molecular Cancer

Fig. 6

From: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer

Fig. 6

Silencing MIR22HG promoters EMT in CRC. a, Enrichment plot of EMT gene sets identified by genes coexpressed with MIR22HG. Blue line representing COAD and green line for READ, FDRs < 0.001. b and c, LoVo and HCT116 cells overexpressing lncRNA-MIR22HG or siMIR22HG were analyzed using bright-field microscopy. d, The expression of EMT relevant markers as determined by qRT-PCR. e, Western blot showing the protein level of EMT relevant markers

Back to article page

Molecular Cancer

ISSN: 1476-4598